Quantcast

Latest Personalized medicine Stories

2014-08-25 08:27:36

-Enhanced Offering to Enable 'Dynamic Monitoring' in Cancer Research- RARITAN, N.J., Aug. 25, 2014 /PRNewswire/ -- Janssen Diagnostics, LLC today announced the addition of next-generation sequencing (NGS) to the portfolio of services it provides pharmaceutical and academic researchers. With this announcement, Janssen Diagnostics continues to drive innovative solutions for its lab services customers by expanding its lab services offering in rare cell detection beyond its core...

2014-08-21 23:01:01

The proteomics market showcases a high growth potential, owing to the growing awareness about personalized medicine and the resultant increase in the use of proteomic technologies-based advancement in the pharmaceutical industry. http://www.marketsandmarkets.com/Market-Reports/proteomics-market-731.html (PRWEB) August 22, 2014 The “Proteomics Market by Technology (Protein Microarray, Mass Spectrometry, NMR Spectroscopy, Chromatography, Electrophoresis, Surface Plasmon Resonance, X-ray...

2014-08-20 12:26:20

LONDON, Aug. 20, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report:Global Personalized Medicines Industryhttps://www.reportbuyer.com/product/2116899/Global-Personalized-Medicines-Industry.htmlThis report analyzes the worldwide markets for Personalized Medicines in US$ Million by the following Product Segments: Targeted Therapeutics, and Tests & Lab Services. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe,...

2014-08-13 16:25:43

Transaction Marks First Step Toward Creation of a Molecular Diagnostics Subsidiary to Aid in Patient Diagnosis and Management PARSIPPANY, N.J., Aug. 13, 2014 /PRNewswire/ -- PDI, Inc. (Nasdaq: PDII), a leading healthcare commercialization company, today announced that its Interpace Diagnostics subsidiary has entered the expanding cancer molecular diagnostics market with the acquisition of the miRInform(®) Thyroid and Pancreas cancer test assets from privately held Asuragen, Inc. This...

2014-08-10 23:00:16

The global metabolomics market is consolidated in nature, wherein the top five players account for more than 70%–75% of the market. http://www.marketsandmarkets.com/Market-Reports/metabolomics-technology-market-900.html (PRWEB) August 11, 2014 According to research report, the “Metabolomics Market by Technique (Gas Chromatography, High Performance Liquid Chromatography, Nuclear Magnetic Resonance Spectroscopy, Mass Spectrometry, by Application (Biomarker & Drug Discovery,...

2014-08-07 12:28:56

ReportsnReports.com offer Global & USA Cancer Biomarker Market to 2018 (Identification, Technologies, Market Analysis, Competitor Profiles, Companion Diagnostic Co-Development, Business Strategies, Industry Trends, and Pipeline Analysis) in its store. DALLAS, Aug. 7, 2014 /PRNewswire-iReach/ -- Global & USA Cancer Biomarker Market to 2018 (Identification, Technologies, Market Analysis, Competitor Profiles, Companion Diagnostic Co-development, Business Strategies, Industry Trends, and...

2014-08-06 08:33:23

LONDON, Aug. 6, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report:Companion Diagnostics in Personalized Medicine and Cancer Therapyhttp://www.reportbuyer.com/pharma_healthcare/diseases/cancer/companion_diagnostics_personalized_medicine_cancer_therapy.html Companion diagnostics (CDx) refers to a particular clinical diagnostic test that is under evaluation and is specifically linked to a known drug therapy. This linkage could be important in the therapeutic...

2014-08-05 23:05:58

Transparency Market Research has announced the addition of the "Companion Diagnostics Market -Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019" report to their offering. Albany,NY (PRWEB) August 05, 2014 Companion diagnostics are the tests or assays which assist physicians in making efficient treatment decisions depending on the patient response to the ongoing treatment. These tests are developed either once the drug is commercialized or along with...

2014-08-05 12:31:40

WASHINGTON, Aug. 5, 2014 /PRNewswire/ -- ImmunoClin Corporation (OTCBB: IMCL) is a U.S. healthcare company specializing in personalized medicine, novel anti-infectious, anti-inflammatory therapies and innovative nutritional formulations. Today, the Company is pleased to announce the appointment of Dr. Heinz Ellerbrok to its Scientific Advisory Board. "Dr. Ellerbrok's extensive expertise in applied molecular diagnostics will be a great asset to our infectious diseases programs and...

2014-08-05 08:32:21

Multidisciplinary physician teams review and discuss cutting edge molecular techniques to assist in personalized cancer therapy for patients. OWASSO, Okla., Aug. 5, 2014 /PRNewswire/ -- The Idaho Society of Clinical Oncology (ISCO) had its first Board of Directors retreat in Sun Valley, ID on July 25-26, 2014. ISCO decided to explore the formation of a state wide tumor board concentrating on cutting edge molecular techniques to provide personalized cancer therapy to the patients in...


Word of the Day
reremouse
  • A bat.
The word 'reremouse' comes from Middle English reremous, from Old English hrēremūs, hrērmūs ("bat"), equivalent to rear (“to move, shake, stir”) +‎ mouse.
Related